Pzena Investment Management LLC Sells 263,665 Shares of CVS Health Corporation $CVS

Pzena Investment Management LLC decreased its stake in shares of CVS Health Corporation (NYSE:CVS) by 1.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,581,307 shares of the pharmacy operator’s stock after selling 263,665 shares during the quarter. CVS Health comprises about 3.7% of Pzena Investment Management LLC’s portfolio, making the stock its 7th biggest holding. Pzena Investment Management LLC’s holdings in CVS Health were worth $1,236,533,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Sei Investments Co. boosted its stake in CVS Health by 17.4% in the 2nd quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator’s stock valued at $62,474,000 after purchasing an additional 134,535 shares during the period. The Manufacturers Life Insurance Company boosted its stake in CVS Health by 1.2% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator’s stock valued at $77,353,000 after purchasing an additional 13,329 shares during the period. Treasurer of the State of North Carolina boosted its stake in CVS Health by 1.3% in the 2nd quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator’s stock valued at $40,358,000 after purchasing an additional 7,588 shares during the period. HUB Investment Partners LLC boosted its stake in CVS Health by 25.0% in the 2nd quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator’s stock valued at $1,039,000 after purchasing an additional 3,011 shares during the period. Finally, Alliancebernstein L.P. boosted its stake in CVS Health by 8.0% in the 2nd quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator’s stock valued at $111,017,000 after purchasing an additional 119,439 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of CVS stock opened at $93.35 on Friday. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78. CVS Health Corporation has a twelve month low of $58.50 and a twelve month high of $98.43. The company has a market cap of $119.11 billion, a P/E ratio of 41.12, a P/E/G ratio of 0.91 and a beta of 0.60. The business has a fifty day simple moving average of $80.03 and a 200 day simple moving average of $78.98.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, topping the consensus estimate of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The business had revenue of $100.43 billion during the quarter, compared to the consensus estimate of $94.99 billion. During the same period in the prior year, the company earned $2.25 EPS. CVS Health’s revenue for the quarter was up 6.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, sell-side analysts forecast that CVS Health Corporation will post 7.44 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, April 23rd. CVS Health’s dividend payout ratio is presently 117.18%.

Insider Transactions at CVS Health

In other CVS Health news, Director Larry Robbins sold 1,983,538 shares of the company’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $94.45, for a total value of $187,345,164.10. Following the completion of the transaction, the director owned 6,213,261 shares of the company’s stock, valued at $586,842,501.45. This represents a 24.20% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Tilak Mandadi sold 69,551 shares of the company’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the completion of the transaction, the executive vice president directly owned 10,133 shares of the company’s stock, valued at approximately $907,714.14. The trade was a 87.28% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 3,441,551 shares of company stock valued at $323,703,977. Insiders own 0.85% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Mizuho boosted their price target on CVS Health from $102.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday. Wall Street Zen upgraded CVS Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. HSBC upped their target price on CVS Health from $83.00 to $85.00 and gave the company a “hold” rating in a research report on Tuesday, May 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of CVS Health in a research report on Friday, May 8th. Finally, Royal Bank Of Canada upped their target price on CVS Health from $93.00 to $107.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Twenty-two analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.68.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Glenview Capital said CVS shares have delivered strong long-term returns and pointed to continued progress in the company’s cultural and operational turnaround, a supportive signal from a notable shareholder. Glenview Capital Issues Statement on CVS Health
• Positive Sentiment: CVS also highlighted new community and public-health initiatives, including senior affordable housing, military support, and maternal mental-health outreach, which reinforce its healthcare platform and brand strength. CVS Health, Diocese of Camden, and The Walters Group Unite to Bring Senior Affordable Housing to Williamstown, New Jersey
• Neutral Sentiment: CVS published several corporate responsibility updates, including support for the military community and women’s health, which are positive for reputation but likely have limited immediate impact on earnings. CVS Health Reinforces Longstanding Support for the Military Community
• Negative Sentiment: Three major hospital systems accused CVS of diverting hundreds of millions of dollars in savings from the federal 340B Drug Pricing Program, increasing legal and reputational risk for the company. Three major hospital systems accuse CVS of secretly siphoning hundreds of millions in drug savings
• Negative Sentiment: Director Larry Robbins disclosed multiple large stock sales over May 19-21, trimming his position by a sizable amount; insider selling can weigh on sentiment even if it does not change the business fundamentals. SEC Form 4 filing

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.